Home/Filings/8-K/0001193125-26-019610
8-K//Current report

ACME UNITED CORP 8-K

Accession 0001193125-26-019610

$ACUCIK 0000002098operating

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 5:03 PM ET

Size

614.1 KB

Accession

0001193125-26-019610

Research Summary

AI-generated summary of this filing

Updated

Acme United Corp Announces Acquisition of My Medic Assets

What Happened
Acme United Corporation filed an 8‑K on January 22, 2026 announcing that it entered into and closed an Asset Purchase Agreement on January 15, 2026 to acquire substantially all assets of SLED Distribution, LLC d/b/a My Medic and Rapid Medical, LLC. The purchase covers the sellers’ business of manufacturing, marketing and selling emergency and first-aid kits, medical packs, tourniquets and related products (direct-to-consumer and other channels).

Key Details

  • Closing and parties: Asset Purchase Agreement dated and closed January 15, 2026 between Acme United and My Medic (SLED Distribution, LLC) and Rapid Medical, LLC.
  • Purchase price: maximum $18,700,000; $14.6 million paid in cash at closing; $4.1 million contingent/held back.
    • $1,000,000 contingent on revenue milestones through the 12 months ended December 31, 2027.
    • $3,100,000 held back as a source of recovery for indemnification claims (subject to claim periods, caps, etc.).
  • Assets acquired: inventory, accounts receivable, prepaid expenses, equipment, intellectual property (patents, trademarks, trade names, copyrights, domain names, social media accounts, related goodwill), customer and supplier relationships, permits and specified contracts.
  • Liabilities: Acme assumed certain liabilities under specified contracts and open purchase orders only; it did not assume other seller liabilities, including excluded assets, pre-closing operations, or pre-closing taxes. The agreement includes customary representations, warranties, covenants, indemnities, transition services and post-closing obligations.

Why It Matters
This transaction adds a tactical/trauma and emergency-response product line and related intellectual property and customer relationships to Acme’s portfolio, expanding its direct-to-consumer and first-aid offerings. The company made a material cash outlay ($14.6M) and retains potential contingent obligations up to $4.1M, which investors should consider when assessing near-term liquidity and potential future cash flow. The limited assumption of seller liabilities and the indemnity/holdback structure are intended to reduce Acme’s exposure to pre-closing risks. The Asset Purchase Agreement and a press release were furnished as exhibits to the 8‑K.